Liquid
CAUTIONARY AND ADVISORY LABELS 28
EXCIPIENTS:May contain Disodium edetate
▶Diprosalic(Merck Sharp & Dohme Ltd)
Betamethasone (as Betamethasone dipropionate)
500 microgram per 1 ml, Salicylic acid 20 mg per 1 mlDiprosalic
0. 05 %/ 2 % scalp application| 100 mlP£ 10. 10 DT = £ 10. 10
Clobetasol propionate with neomycin
sulfate and nystatin
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, clobetasol propionate p. 736 , neomycin
sulfate p. 722.
lINDICATIONS AND DOSE
Short-term treatment only of severe resistant
inflammatory skin disorders such as recalcitrant
eczemas associated with infection and unresponsive to
less potent corticosteroids|Psoriasis associated with
infection
▶TO THE SKIN
▶Child:(consult product literature)
POTENCY
▶Clobetasol propionate 0. 05 % with neomycin sulfate and
nystatin cream and ointment: very potent.
lUNLICENSED USEClobetasol with neomycin and nystatin
preparations not licensed for use in children under 2 years.
lPATIENT AND CARER ADVICEPatients or carers should be
advised on application of clobetasol propionate, neomycin
sulfate and nystatin containing preparations.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ointment
CAUTIONARY AND ADVISORY LABELS 28
▶Clobetasol propionate with neomycin sulfate and nystatin (Non-
proprietary)
Clobetasol propionate 500 microgram per 1 gram, Neomycin
sulfate 5 mg per 1 gram, Nystatin 100000 unit per
1 gramClobetasol 500 microgram / Neomycin 5 mg / Nystatin
100 , 000 units/g ointment| 30 gramP£ 87. 00 DT = £ 87. 00
Cream
CAUTIONARY AND ADVISORY LABELS 28
▶Clobetasol propionate with neomycin sulfate and nystatin (Non-
proprietary)
Clobetasol propionate 500 microgram per 1 gram, Neomycin
sulfate 5 mg per 1 gram, Nystatin 100000 unit per
1 gramClobetasol 500 microgram / Neomycin 5 mg / Nystatin
100 , 000 units/g cream| 30 gramP£ 87. 00 DT = £ 87. 00
Clobetasone butyrate with nystatin
and oxytetracycline
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, clobetasone butyrate p. 737 , oxytetracycline
p. 354.
lINDICATIONS AND DOSE
Steroid-responsive dermatoses where candidal or
bacterial infection is present
▶TO THE SKIN
▶Child:(consult product literature)
POTENCY
▶Clobetasone butyrate 0. 05 % with nystatin and
oxytetracyline cream: moderate.
lPATIENT AND CARER ADVICEStains clothing.
lMEDICINAL FORMS
Forms available from special-order manufacturers include:
cream
Fluocinolone acetonide with clioquinol
The properties listed below are those particular to the
combination only. For the properties of the components
please consider,fluocinolone acetonide p. 738.
lINDICATIONS AND DOSE
Inflammatory skin disorders such as eczemas associated
with infection|Psoriasis associated with infection
▶TO THE SKIN
▶Child:Apply 1 – 2 times a day, to be applied thinly,
reducing strength as condition responds
POTENCY
▶Clioquinol 3 % withfluocinolone acetonide 0. 025 %
cream and ointment: potent
lPATIENT AND CARER ADVICEPatient counselling is advised
for clioquinol withfluocinolone acetonide cream and
ointment (application). Ointment stains clothing.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ointment
CAUTIONARY AND ADVISORY LABELS 28
EXCIPIENTS:May contain Propylene glycol, woolfat and related
substances (including lanolin)
▶Synalar C(Reig Jofre UK Ltd)
Fluocinolone acetonide 250 microgram per 1 gram, Clioquinol
30 mg per 1 gramSynalar C ointment| 15 gramP£ 2. 66
Cream
CAUTIONARY AND ADVISORY LABELS 28
EXCIPIENTS:May contain Cetostearyl alcohol (including cetyl and
stearyl alcohol), disodium edetate, hydroxybenzoates (parabens),
polysorbates, propylene glycol
▶Synalar C(Reig Jofre UK Ltd)
Fluocinolone acetonide 250 microgram per 1 gram, Clioquinol
30 mg per 1 gramSynalar C cream| 15 gramP£ 2. 66
Fluocinolone acetonide with neomycin
The properties listed below are those particular to the
combination only. For the properties of the components
please consider,fluocinolone acetonide p. 738 , neomycin
sulfate p. 722.
lINDICATIONS AND DOSE
Inflammatory skin disorders such as eczemas associated
with infection|Psoriasis associated with infection
▶TO THE SKIN
▶Child 1–11 months:Apply 1 – 2 times a day, to be applied
thinly, reducing strength as condition responds
▶Child 1–17 years:Apply 1 – 2 times a day, to be applied
thinly, reducing strength as condition responds
POTENCY
▶Fluocinolone acetonide 0. 025 % with neomycin 0. 5 %
cream and ointment: potent.
lPATIENT AND CARER ADVICEPatients or carers should be
counselled on the application offluocinolone acetonide
with neomycin preparations.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ointment
CAUTIONARY AND ADVISORY LABELS 28
EXCIPIENTS:May contain Propylene glycol, woolfat and related
substances (including lanolin)
742 Inflammatory skin conditions BNFC 2018 – 2019
Skin
13